We have synthesized two ligand systems, N(SO 2 )(R 1 )dpa (L1) and N(SO 2 )(R 2 )dpa (L2), where R 1 = biphenyl and R 2 = azobenzene, which are sulfonamide derivatives of the NNN-donor chelating dipicolylamine. Both L1 and L2 can be used as sensors for detecting Fe 3+ and are highly sensitive and selective over a wide range of common cations. Time-dependent density functional theory (TDDFT) calculations confirmed that the key excitations of L2 and the [Fe(L2)(H 2 O) 3 ] 3+ model complex involve −R 2 -unit-based π and π* charge transfer. L2 demonstrates a relatively high photostability, a fluorescence turn-on mechanism, and a detection limit of 0.018 μM with 1.00 μM L2 concentration, whereas L1 has a detection limit of 0.67 μM. Thus, both ligands have the potential to be used as fluorosensors for the detection of Fe 3+ in aqueous solutions.
Neutral and cationic rhenium complexes provide both hydrophilic as well as hydrophobic properties due to the robustness of the tridentate ligand system of biphenyl appended dipicolylamine (N(SO2bip)dpa) and diethylenetriamine (N(SO2bip)dienH) coordinated to the [Re(CO)3]+ core, hold immense potential for the development of metal based anticancer drugs. This was achieved by the synthesis of two ligands (L1: N(SO2bip)dpa and L2: (N(SO2bip)dienH) and their corresponding Re complexes (C1: [Re(CO)3(N(SO2bip)dpa)]PF6 and C2: [Re(CO)3(N(SO2bip)dien)] in good yield and high purity. All four compounds were characterized by 1H NMR, UV-Vis, FTIR spectroscopies and L1, also by single crystal X-ray diffraction. The methylene protons observed as a singlet at (4.59 ppm) in a 1H NMR spectrum of L1 appear as two doublets (5.66 and 4.65 ppm) in the spectrum of C1. The appearance of NH signals at 3.48, 5.17 and 6.69 ppm in the 1H NMR spectrum of C2 confirm the coordination of L2 with Re. The stretching vibration frequencies depicted by the S-N bond at 923 cm-1 for L1 appear towards lower frequencies (821 cm-1) in an FTIR spectrum of C1, while the S-N bond at 943 cm-1 for L2 appears towards higher frequencies (968 cm-1) in C2. In silico assessment of drug likeliness revealed zero violations demonstrating a high likeliness of the ligands to be successful as drug leads. All four compounds have shown very low IC50 values against non-small cell lung cancer cells (NCI-H292). Therefore, L1, C1, L2 and C2 are promising novel compounds that can be further investigated as potential anticancer agents. Keywords: Rhenium Tricarbonyl, Sulfonamide, Anticancer, Fluorescence.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.